Literature DB >> 30968162

Improvement of stress tolerance and riboflavin production of Bacillus subtilis by introduction of heat shock proteins from thermophilic bacillus strains.

Junyang Wang1,2, Weishan Wang1, Huizhuan Wang3, Fang Yuan3, Zhen Xu3, Keqian Yang1, Zilong Li4, Yihua Chen5,6, Keqiang Fan7.   

Abstract

In this study, stress tolerance devices consisting of heat shock protein (HSP) genes from thermophiles Geobacillus and Parageobacillus were introduced into riboflavin-producing strain Bacillus subtilis 446 to improve its stress tolerance and riboflavin production. The 12 HSP homologs were selected from 28 Geobacillus and Parageobacillus genomes according to their sequence clustering and phylogenetically analysis which represents the diversity of HSPs from thermophilic bacillus. The 12 HSP genes and 2 combinations of them (PtdnaK-PtdnaJ-PtgrpE and PtgroeL-PtgroeS) were heterologously expressed in B. subtilis 446 under the control of a strong constitutive promoter P43. Most of the 14 engineered strains showed increased cell density at 44 to 48 °C and less cell death at 50 °C compared with the control strains. Among them, strains B.s446-HSP20-3, B.s446-HSP20-2, and B.s446-PtDnaK-PtDnaJ-PtGrpE increased their cell densities over 25% at 44 to 48 °C. They also showed 5-, 4-, and 4-fold improved cell survivals after the 10-h heat shock treatment at 50 °C, respectively. These three strains also showed reduced cell death rates under osmotic stress of 10% NaCl, indicating that the introduction of HSPs improved not only the heat tolerance of B. subtilis 446 but also its osmotic tolerance. Fermentation of these three strains at higher temperatures of 39 and 43 °C showed 23-66% improved riboflavin titers, as well as 24-h shortened fermentation period. These results indicated that implanting HSPs from thermophiles to B. subtilis 446 would be an efficient approach to improve its stress tolerance and riboflavin production.

Entities:  

Keywords:  Heat tolerance; Molecular chaperones; Osmotic tolerance; Riboflavin production

Mesh:

Substances:

Year:  2019        PMID: 30968162     DOI: 10.1007/s00253-019-09788-x

Source DB:  PubMed          Journal:  Appl Microbiol Biotechnol        ISSN: 0175-7598            Impact factor:   4.813


  7 in total

Review 1.  Recent advances in improving metabolic robustness of microbial cell factories.

Authors:  Tian Jiang; Chenyi Li; Yuxi Teng; Ruihua Zhang; Yajun Yan
Journal:  Curr Opin Biotechnol       Date:  2020-07-16       Impact factor: 9.740

2.  Cis-Element Engineering Promotes the Expression of Bacillus subtilis Type I L-Asparaginase and Its Application in Food.

Authors:  Jiafeng Niu; Ruxue Yan; Juan Shen; Xiaoyu Zhu; Fanqiang Meng; Zhaoxin Lu; Fengxia Lu
Journal:  Int J Mol Sci       Date:  2022-06-13       Impact factor: 6.208

3.  Engineered Bacillus subtilis for the de novo production of 2'-fucosyllactose.

Authors:  Quanwei Zhang; Zhenmin Liu; Hongzhi Xia; Ziyang Huang; Yonglian Zhu; Linfeng Xu; Yanfeng Liu; Jianghua Li; Guocheng Du; Xueqin Lv; Long Liu
Journal:  Microb Cell Fact       Date:  2022-06-02       Impact factor: 6.352

Review 4.  Production of riboflavin and related cofactors by biotechnological processes.

Authors:  Shuang Liu; Wenya Hu; Zhiwen Wang; Tao Chen
Journal:  Microb Cell Fact       Date:  2020-02-13       Impact factor: 5.328

Review 5.  Bacillus subtilis: a universal cell factory for industry, agriculture, biomaterials and medicine.

Authors:  Yuan Su; Chuan Liu; Huan Fang; Dawei Zhang
Journal:  Microb Cell Fact       Date:  2020-09-03       Impact factor: 5.328

Review 6.  Strategies to Increase the Production of Biosynthetic Riboflavin.

Authors:  Guiling Zhao; Fanyi Dong; Xingzhen Lao; Heng Zheng
Journal:  Mol Biotechnol       Date:  2021-06-22       Impact factor: 2.695

7.  Engineering thermophilic Geobacillus thermoglucosidasius for riboflavin production.

Authors:  Zhiheng Yang; Qingqing Sun; Gaoyi Tan; Quanwei Zhang; Zhengduo Wang; Chuan Li; Fengxian Qi; Weishan Wang; Lixin Zhang; Zilong Li
Journal:  Microb Biotechnol       Date:  2020-02-25       Impact factor: 5.813

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.